Pelvic exenteration for advanced pelvic malignancies

Annals of Surgical Oncology

Volumn 13, Issue 5, 2006, Pages 612-623

  Pawlik, Timothy M ^a,b   Skibber, John M ^a   Rodriguez Bigas, Miguel A ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Morbidity; Outcome; Pelvic exenteration; Pelvic malignancy; Rectal cancer; Review

Indexed keywords

FLUOROURACIL; FOLINIC ACID;

ADJUVANT THERAPY; ADVANCED CANCER; ANALGESIA; ASPIRATION BIOPSY; BLEEDING; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COLORECTAL CANCER; COLOSTOMY; COMPOSITE PELVIC EXENTERATION; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; ILEOSTOMY; INTESTINE OBSTRUCTION; LAPAROTOMY; LYMPH NODE; METASTASIS; MODIFIED PELVIC EXENTERATION; MORBIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PALLIATIVE THERAPY; PELVIS ABSCESS; PELVIS CANCER; PELVIS EXENTERATION; PELVIS PAIN SYNDROME; PELVIS SURGERY; PERIOPERATIVE PERIOD; PHYSICAL EXAMINATION; PLASTIC SURGERY; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; QUALITY OF LIFE; RADIATION DOSE; RECTUM CANCER; REVIEW; SURGEON; SURGICAL MORTALITY; SURGICAL TECHNIQUE; SURVIVAL RATE; THORAX RADIOGRAPHY; TOTAL PELVIC EXENTERATION; TUMOR VOLUME; URINARY DIVERSION; URINARY TRACT FISTULA; UTERINE CERVIX CANCER; VAGINA RECONSTRUCTION;

HUMANS; PALLIATIVE CARE; PATIENT SELECTION; PELVIC EXENTERATION; PELVIC NEOPLASMS; SURVIVAL RATE;

EID: 33645845755     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/ASO.2006.03.082     Document Type: Review

References (128)

1. Anthopoulos AP, Manetta A, Larson JE, Podczaski ES, Bartholomew MJ, Mortel R. Pelvic exenteration: a morbidity, mortality analysis of a seven-year experience. Gynecol Oncol 1989;35:219-23.
2. Kiselow M, Butcher HR, Bricker EM. Results of the radical surgical treatment of advanced pelvic cancer. Ann Surg 1967;166:428-36.
3. Soper JT, Berchuck A, Creasman WT, Clarke-Pearson DL. Pelvic exenteration: factors associated with major surgical morbidity. Gynecol Oncol 1989;35:93-8.
4. Hafner GH, Herrera L, Petrelli NJ. Morbidity, mortality after pelvic exenteration for colorectal adenocarcinoma. Ann Surg 1992;215:63-7.
5. Lopez MJ, Monafo WW. Role of extended resection in the initial treatment of locally advanced colorectal carcinoma. Surgery 1993;113:365-72.
6. Kraybill WG, Lopez MJ, Bricker EM. Total pelvic exenteration as a therapeutic option in advanced malignant disease of the pelvis. Surg Gynecol Obstet 1988;166:259-63.
7. Averette HE, Lichtinger M, Sevin BU, Girtanner RE. Pelvic exenteration: a 15-year experience in a general metropolitan hospital. Am J Obstet Gynecol 1984;150:179-84.
8. Brunschwig A. Complete excision of pelvic viscera for advanced carcinoma. Cancer 1948;1:177-83.
9. Avradopoulos KA, Vezeridis MP, Wanebo HJ. Pelvic exenteration for recurrent rectal cancer. Adv Surg 1996;29:215-33.
10. Plukker JT, Aalders JG, Mensink HJ, Oldhoff J. Total pelvic exenteration: a justified procedure. Br J Surg 1993;80:1615-7.
11. Lopez MJ, Standiford SB, Skibba JL. Total pelvic exenteration. A 50-year experience at the Ellis Fischel Cancer Center. Arch Surg 1994;129:390-5; discussion 5-6.
12. Goldberg JM, Piver MS, Hempling RE, Aiduk C, Blumenson L, Recio FO. Improvements in pelvic exenteration: factors responsible for reducing morbidity and mortality. Ann Surg Oncol 1998;5:399-406.
13. Ravi R. Second primary bladder cancer following pelvic irradiation for other malignancies. J Surg Oncol 1993;54:60-3.
14. Eisenkop SM, Spirtos NM. Procedures required to accomplish complete cytoreduction of ovarian cancer: is there a correlation with "biological aggressiveness" and survival? Gynecol Oncol 2001;82:435-41.
15. Eisenkop SM, Nalick RH, Teng NN. Modified posterior exenteration for ovarian cancer. Obstet Gynecol 1991;78:879-85.
16. Kamat AM, Huang SF, Bermejo CE, et al. Total pelvic exenteration: effective palliation of perineal pain in patients with locally recurrent prostate cancer. J Urol 2003;170:1868-71.
17. Reid GC, Morley GW, Schmidt RW, Hopkins MP. The role of pelvic exenteration for sarcomatous malignancies. Obstet Gynecol 1989;74:80-4.
18. Spratt JS, Watson R, Pratt JL. Characteristics of variants of colorectal carcinoma that do not metastasize to lymph nodes. Dis Colon Rectum 1970;13:243-6.
19. Grinnell RS. Lymphatic block with atypical and retrograde lymphatic metastases and spread in carcinoma of the colon and rectum. Am Surg 1966;63:272-80.
20. Rodriguez-Bigas MA, Petrelli NJ. Pelvic exenteration and its modifications. Am J Surg 1996;171:293-8.
21. Lopez MJ. Exenterative pelvic surgery. Surg Clin North Am 1994;3:197-218.
22. Bonfanti G, Bozzetti F, Doci R, et al. Results of extended surgery for cancer of the rectum and sigmoid. Br J Surg 1982;69:305-7.
23. Rodriguez-Bigas MA, Petrelli NJ, Lopez MJ, Petros JG. Modified pelvic exenterations. Surg Oncol Clin North Am 1994;3:239-46.
24. Heald RJ. Total mesorectal excision. The new European gold standard. G Chir 1998;19:253-5.
25. Carlsen E, Schlichting E, Guldvog I, Johnson E, Heald RJ. Effect of the introduction of total mesorectal excision for the treatment of rectal cancer. Br J Surg 1998;85:526-9.
26. Havenga K, Enker WE, Norstein J, et al. Improved survival and local control after total mesorectal excision or D3 lymphadenectomy in the treatment of primary rectal cancer: an international analysis of 1411 patients. Eur J Surg Oncol 1999;25:368-74.
27. Cass AW, Million RR, Pfaff WW. Patterns of recurrence following surgery alone for adenocarcinoma of the colon and rectum. Cancer 1976;37:2861-5.
28. Kakuda JT, Lamont JP, Chu DZ, Paz IB. The role of pelvic exenteration in the management of recurrent rectal cancer. Am J Surg 2003;186:660-4.
29. Wanebo HJ, Gaker DL, Whitehill R, Morgan RF, Constable WC. Pelvic recurrence of rectal cancer. Options for curative resection. Ann Surg. 1987;205:482-95.
30. Landoni F, Maneo A, Colombo A, et al. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet 1997;350:535-40.
31. Pearson B. Factors in the cause of death in carcinoma of the cervix. Am J Cancer 1936;28:31-9.
32. Crowe PJ, Temple WJ, Lopez MJ, Ketcham AS. Pelvic exenteration for advanced pelvic malignancy. Semin Surg Oncol 1999;17:152-60.
33. Montana GS, Fowler WC, Varia MA, Walton LA, Mack Y, Shemanski L. Carcinoma of the cervix, stage III. Results of radiation therapy. Cancer 1986;57:148-54.
34. Rutledge FN, Smith JP, Wharton JT, O'Quinn AG. Pelvic exenteration: analysis of 296 patients. Am J Obstet Gynecol 1977;129:881-92.
35. Finlayson CA, Eisenberg BL. Palliative pelvic exenteration: patient selection and results. Oncology (Huntingt) 1996;10:479-84; discussion 84-6, 90, 93.
36. McCullough WM, Nahhas WA. Palliative pelvic exenteration - futility revisited. Gynecol Oncol 1987;27:97-103.
37. Hafner GH, Herrera L, Petrelli NJ. Patterns of recurrence after pelvic exenteration for colorectal adenocarcinoma. Arch Surg 1991;126:1510-3.
38. Lawhead RA Jr, Clark DG, Smith DH, Pierce VK, Lewis JL Jr. Pelvic exenteration for recurrent or persistent gynecologic malignancies: a 10-year review of the Memorial Sloan-Kettering Cancer Center experience (1972-1981). Gynecol Oncol 1989;33:279-82.
39. Hatch KD, Gelder MS, Soong SJ, Baker VV, Shingleton HM. Pelvic exenteration with low rectal anastomosis: survival, complications, and prognostic factors. Gynecol Oncol 1990;38:462-7.
40. Rodriguez-Bigas MA, Herrera L, Petrelli NJ. Surgery for recurrent rectal adenocarcinoma in the presence of hydronephrosis. Am J Surg 1992;164:18-21.
41. Brophy PF, Hoffman JP, Eisenberg BL. The role of palliative pelvic exenteration. Am J Surg 1994;167:386-90.
42. Lopez MJ, Kraybill WG, Downey RS, Johnston WD, Bricker EM. Exenterative surgery for locally advanced rectosigmoid cancers. Is it worthwhile? Surgery 1987;102:644-51.
43. Deckers PJ, Olsson C, Williams LA, Mozden PJ. Pelvic exenteration as palliation of malignant disease. Am J Surg 1976;131:509-15.
44. Woodhouse CR, Plail RO, Schlesinger PE, Shepherd JE, Hendry WF, Breach NM. Exenteration as palliation for patients with advanced pelvic malignancy. Br J Urol 1995;76:315-20.
45. Esnaola NF, Cantor SB, Johnson ML, et al. Pain and quality of life after treatment in patients with locally recurrent rectal cancer. J Clin Oncol 2002;20:4361-7.
46. Miller AR, Cantor SB, Peoples GE, Pearlstone DB, Skibber JM. Quality of life and cost effectiveness analysis of therapy for locally recurrent rectal cancer. Dis Colon Rectum 2000;43:1695-701; discussion 701-3.
47. Sasson AR, Sigurdson ER. Management of locally advanced rectal cancer. Surg Oncol 2000;9:193-204.
48. Yeung RS, Moffat FL, Falk RE. Pelvic exenteration for recurrent and extensive primary colorectal adenocarcinoma. Cancer 1993;72:1853-8.
49. Lichtinger M, Averette H, Penalver M, Sevin BU. Major surgical procedures for gynecologic malignancy in elderly women. South Med J 1986;79:1506-10.
50. Matthews CM, Morris M, Burke TW, Gershenson DM, Wharton JT, Rutledge FN. Pelvic exenteration in the elderly patient. Obstet Gynecol 1992;79:773-7.
51. Bricker EM, Kraybill WG, Lopez MJ, Johnston WD. The current role of ultraradical surgery in the treatment of pelvic cancer. Curr Probl Surg 1986;23:869-953.
52. Salom EM, Penalver MA. Pelvic exenteration and reconstruction. Cancer J 2003;9:415-24.
53. Vining DJ. Rectal imaging and cancer. Semin Surg Oncol 1998;15:72-7.
54. Cance WG, Cohen AM, Enker WE, Sigurdson ER. Predictive value of a negative computed tomographic scan in 100 patients with rectal carcinoma. Dis Colon Rectum 1991;34:748-51.
55. Zeiler H, Joura EA, Moeschl P. Preoperative evaluation of tumor extension in patients with recurrent cervical cancer. Act Obstet Gynecol Scand 1997;76:474-84.
56. Dozois RR, Perry RE. Rectal cancer: current management. Curr Probl Surg 1990;27:243-99.
57. Beets-Tan RG, Beets GL, Borstlap AC, et al. Preoperative assessment of local tumor extent in advanced rectal cancer: CT or high-resolution MRI?. Abdom Imaging 2000;25: 533-41.
58. Popovich MJ, Hricak H, Sugimura K, Stern JL. The role of MR imaging in determining surgical eligibility for pelvic exenteration. AJR Am J Roentgenol 1993;160:525-31.
59. Smith FW, Heys SD, Evans NT, et al. Pattern of 2-deoxy-2-[18F]-fluro-D-glucose accumulation in liver tumours: primary, metastatic and after chemotherapy. Nucl Med Commun 1992;13:193-5.
60. Engenhart R, Kimmig BN, Strauss LG. Therapy monitoring of presacral recurrences after high-dose irradiation: value of PET, CT, CEA and pain score. Strahlenther Onkol 1992;13: 193-5.
61. Morley GW, Hopkins MP, Lindenauer SM, Roberts JA. Pelvic exenteration, University of Michigan: 100 patients at 5 years. Obstet Gynecol 1989;74:934-43.
62. Tarraza HM, Ellerkmann RM. Pelvic radical surgery. Surg Oncol Clin North Am 1998;7:399-416.
63. Van Dyke AH Van, Nagell JR Jr. The prognostic significance of ureteral obstruction in patients with recurrent carcinoma of the cervix uteri. Surg Gynecol Obstet 1975;141:371-3.
64. Heslov SF, Frost DB. Extended resection for primary colorectal carcinoma involving adjacent organs or structures. Cancer 1988;62:1637-40.
65. Gall FP, Tonak J, Altendorf A. Multivisceral resections in colorectal cancer. Dis Colon Rectum 1987;30:337-41.
66. McGlone TP, Bernie WA, Elliott DW. Survival following extended operations for extracolonic invasion by colon cancer. Arch Surg 1982;117:595-9.
67. Eisenberg SB, Kraybill WG, Lopez MJ. Long-term results of surgical resection of locally advanced colorectal carcinoma. Surgery 1990;108:779-85discussion 85-6.
68. Magrina JF, Stanhope CR, Weaver AL. Pelvic exenterations: supralevator, infralevator, and with vulvectomy. Gynecol Oncol 1997;64:130-5.
69. Lopez MJ. (1993) Pelvic exenteration. In: Cady B, Daly J (eds). Atlas of Surgical Oncology. Mosby-Year Book, Chicago, p 555.
70. Magrina JF. Types of pelvic exenterations: a reappraisal. Gynecol Oncol 1990;37:363-6.
71. Takagi H, Morimoto T, Kato T, Yasue M, Endo T, Suzuki R. Pelvic exenteration combined with sacral resection for recurrent rectal cancer. J Surg Oncol 1983;24:161-6.
72. Wanebo HJ, Koness RJ, Vezeridis MP, Cohen SI, Wrobleski DE. Pelvic resection of recurrent rectal cancer. Ann Surg 1994;220:586-95; discussion 95-7.
73. Sugarbaker PH. Partial sacrectomy for en bloc excision of rectal cancer with posterior fixation. Dis Colon Rectum 1982;25:708-11.
74. Temple WJ, Ketcham AS. Sacral resection for control of pelvic tumors. Am J Surg 1992;163:370-4.
75. Wanebo HJ, Antoniuk P, Koness RJ, et al. Pelvic resection of recurrent rectal cancer: technical considerations and outcomes. Dis Colon Rectum 1999;42:1438-48.
76. Wanebo HJ, Marcove RC. Abdominal sacral resection of locally recurrent rectal cancer. Ann Surg 1981;194:458-71.
77. Ehrlich RM. An improved method of creating an ileac conduit: the importance of a better vascular supply. J Urol 1973;109:993-5.
78. Rowland RG, Mitchell ME, Bihrle R, Kahnoski RJ, Piser JE. Indiana continent urinary reservoir. J Urol 1987;137:1136-9.
79. Montie JE, MacGregor PS, Fazio VW, Lavery I. Continent ileal urinary reservoir (Kock pouch). Urol Clin North Am 1986;13:251-60.
80. Skinner DG, Lieskovsky G, Boyd S. Continent urinary diversion. J Urol 1989;141:1323-7.
81. Lockhart JL, Pow-Sang JM, Persky L, Kahn P, Helal M, Sanford E. A continent colonic urinary reservoir: the Florida pouch. J Urol 1990;144:864-7.
82. Bejany DE, Politano VA. Stapled and nonstapled tapered distal ileum for construction of a continent colonic urinary reservoir. J Urol 1988;140:491-4.
83. Penalver MA, Bejany D, Donato DM, Sevin BU, Averette HE. Functional characteristics and follow-up of the continent ileal colonic urinary reservoir. Miami pouch. Cancer 1993;71:1667-72.
84. Pursell SH, Day TG Jr, Tobin GR. Distally based rectus abdominis flap for reconstruction in radical gynecologic procedures. Gynecol Oncol 1990;37:234-8.
85. Tobin GR, Day TG. Vaginal and pelvic reconstruction with distally based rectus abdominis myocutaneous flaps. Plast Reconstr Surg 1988;81:62-73.
86. Khoo AK, Skibber JM, Nabawi AS, et al. Indications for immediate tissue transfer for soft tissue reconstruction in visceral pelvic surgery. Surgery 2001;130:463-9.
87. Buchel EW, Finical S, Johnson C. Pelvic reconstruction using vertical rectus abdominis musculocutaneous flaps. Ann Plast Surg 2004;52:22-6.
88. Shibata D, Hyland W, Busse P, et al. Immediate reconstruction of the perineal wound with gracilis muscle flaps following abdominoperineal resection and intraoperative radiation therapy for recurrent carcinoma of the rectum. Ann Surg Oncol 1999;6:33-7.
89. Andersen BL, Hacker NF. Psychosexual adjustment following pelvic exenteration. Obstet Gynecol 1983;61:331-8.
90. Corney RH, Crowther ME, Everett H, Howells A, Shepherd JH. Psychosexual dysfunction in women with gynaecological cancer following radical pelvic surgery. Br J Obstet Gynaecol 1993;100:73-8.
91. Beemer W, Hopkins MP, Morley GW. Vaginal reconstruction in gynecologic oncology. Obstet Gynecol 1988;72:911-4.
92. Hatch KD. Neovaginal reconstruction. Cancer 1993;71:1660-3.
93. Benson C, Soisson AP, Carlson J, Culbertson G, Hawley-Bowland C, Richards F. Neovaginal reconstruction with a rectus abdominis myocutaneous flap. Obstet Gynecol 1993;81:871-5.
94. Jurado M, Bazan A, Elejabeitia J, Paloma V, Martinez-Monge R, Alcazar JL. Primary vaginal and pelvic floor reconstruction at the time of pelvic exenteration: a study of morbidity. Gynecol Oncol 2000;77:293-7.
95. Roberts WS, Cavanagh D, Bryson SC, Lyman GH, Hewitt S. Major morbidity after pelvic exenteration: a seven-year experience. Obstet Gynecol 1987;69:617-21.
96. Talledo OE. Pelvic exenteration - Medical College of Georgia experience. Gynecol Oncol 1985;22:181-8.
97. Orr JW Jr, Shingleton HM, Hatch KD, Taylor PT, Partridge EE, Soong SJ. Gastrointestinal complications associated with pelvic exenteration. Am J Obstet Gynecol 1983;145:325-32.
98. Petrelli N, Rosenfield L, Herrera L, Mittelman A. The morbidity of perineal wounds following abdominoperineal resection for rectal carcinoma. J Surg Oncol 1986;32:138-40.
99. Wilson TG, Moreno JG, Weinberg A, Ahlering TE. Late complications of the modified Indiana pouch. J Urol 1994;151:331-4.
100. Ordorica RC, Masel J, Seigne J, Persky L, Lockhart JL. Evaluation and management of mechanical dysfunction in continent colonic urinary reservoirs. J Urol 2000;163:1679-84.
101. Penalver M, Donato D, Sevin BU, Bloch WE, Alvarez WJ, Averette H. Complications of the ileocolonic continent urinary reservoir (Miami pouch). Gynecol Oncol 1994;52:360-4.
102. Angioli R, Estape R, Cantuaria G, et al. Urinary complications of Miami pouch: trend of conservative management. Am J Obstet Gynecol 1998;179:343-8.
103. Ramirez PT, Modesitt SC, Morris M, et al. Functional outcomes and complications of continent urinary diversions in patients with gynecologic malignancies. Gynecol Oncol 2002;85:285-91.
104. Bladou F, Houvenaeghel G, Delpero JR, Guerinel G. Incidence and management of major urinary complications after pelvic exenteration for gynecological malignancies. J Surg Oncol 1995;58:91-6.
105. Jakowatz JG, Porudominsky D, Riihimaki DU, et al. Complications of pelvic exenteration. Arch Surg 1985;120:1261-5.
106. Dervanian P, Castaigne D, Travagli JP, et al. Arterioureteral fistula after extended resection of pelvic tumors: report of three cases and review of the literature. Ann Vasc Surg 1992;6:362-9.
107. Rutledge FN, McGuffee VB. Pelvic exenteration: prognostic significance of regional lymph node metastasis. Gynecol Oncol 1987;26:374-80.
108. Moriya Y, Akasu T, Fujita S, Yamamoto S. Total pelvic exenteration with distal sacrectomy for fixed recurrent rectal cancer in the pelvis. Dis Colon Rectum 2004;47:2047-53; discussion 53-4.
109. Law WL, Chu KW, Choi HK. Total pelvic exenteration for locally advanced rectal cancer. J Am Coll Surg 2000;190:78-83.
110. Ike H, Shimada H, Yamaguchi S, Ichikawa Y, Fujii S, Ohki S. Outcome of total pelvic exenteration for primary rectal cancer. Dis Colon Rectum 2003;46:474-80.
111. Chen HS, Sheen-Chen SM. Total pelvic exenteration for primary local advanced colorectal cancer. World J Surg 2001;25:1546-9.
112. Ike H, Shimada H, Ohki S, Yamaguchi S, Ichikawa Y, Fujii S. Outcome of total pelvic exenteration for locally recurrent rectal cancer. Hepatogastroenterology 2003;50:700-3.
113. Salo JC, Paty PB, Guillem J, Minsky BD, Harrison LB, Cohen AM. Surgical salvage of recurrent rectal carcinoma after curative resection: a 10-year experience. Ann Surg Oncol 1999;6:171-7.
114. Sanfilippo NJ, Crane CH, Skibber J, et al. T4 rectal cancer treated with preoperative chemoradiation to the posterior pelvis followed by multivisceral resection: patterns of failure and limitations of treatment. Int J Radiat Oncol Biol Phys 2001;51:176-83.
115. Hida J, Yasutomi M, Maruyama T, et al. Results from pelvic exenteration for locally advanced colorectal cancer with lymph node metastases. Dis Colon Rectum 1998;41:165-8.
116. Ledesma EJ, Bruno S, Mittelman A. Total pelvic exenteration in colorectal disease: a 20-year experience. Ann Surg 1981;194:701-3.
117. Shirouzu K, Isomoto H, Kakegawa T. Total pelvic exenteration for locally advanced colorectal carcinoma. Br J Surg 1996;83:32-5.
118. Liu SY, Wang YN, Zhu WQ, Gu WL, Fu H. Total pelvic exenteration for locally advanced rectal carcinoma. Dis Colon Rectum 1994;37:172-4.
119. Rodriguez Cuevas H, Torres A, la Garza M, Hernandez D, Herrera L. Pelvic exenteration for carcinoma of the cervix: analysis of 252 cases. J Surg Oncol 1988;38:121-5.
120. Shingleton HM, Soong SJ, Gelder MS, Hatch KD, Baker VV, Austin JM Jr. Clinical and histopathologic factors predicting recurrence and survival after pelvic exenteration for cancer of the cervix. Obstet Gynecol 1989;73:1027-34.
121. Mendenhall WM, Million RR, Bland KI, Pfaff WW, Copeland EM III. Initially unresectable rectal adenocarcinoma treated with preoperative irradiation and surgery. Ann Surg 1987;205:41-4.
122. Emami B, Pilepich M, Willett C, Munzenrider JE, Miller HH. Effect of preoperative irradiation on resectability of colorectal carcinomas. Int J Radiat Oncol Biol Phys 1982;8:1295-9.
123. Stevens KR Jr, Allen CV, Fletcher WS. Preoperative radiotherapy for adenocarcinoma of the rectosigmoid. Cancer 1976;37:2866-74.
124. Dosoretz DE, Gunderson LL, Hedberg S, et al. Preoperative irradiation for unresectable rectal and rectosigmoid carcinomas. Cancer 1983;52:814-8.
125. Minsky BD, Cohen AM, Kemeny N, et al. The efficacy of preoperative 5-fluorouracil, high-dose leucovorin, and sequential radiation therapy for unresectable rectal cancer. Cancer 1993;71:3486-92.
126. Minsky BD, Cohen AM, Kemeny N, et al. Enhancement of radiation-induced downstaging of rectal cancer by fluorouracil and high-dose leucovorin chemotherapy. J Clin Oncol 1992;10:79-84.
127. Meterissian SH, Skibber JM, Giacco GG, El-Naggar AK, Hess KR, Rich TA. Pelvic exenteration for locally advanced rectal carcinoma: factors predicting improved survival. Surgery 1997;121:479-87.
128. Busse PM, Jessup JM, Cady B, et al. Effect of combined modality therapy on the surgical management of locally advanced rectal carcinoma. Semin Surg Oncol 1993;9:46-50.